NANCY ENGER: Open Payments
NPI 1306107875 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 37 payments from 18 companies in 2025. Trend: 2023 $642 · 2024 $667 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $164 |
| ABBVIE INC. | 4 | $104 |
| AstraZeneca Pharmaceuticals LP | 6 | $103 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| Amgen Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $46 |
| PFIZER INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
Products named: WATCHMAN FLX, LEQVIO, QULIPTA, MOUNJARO, UBRELVY, PREVNAR 20, BREZTRI, SHINGRIX.
Industry payments across MO — which companies pay providers there.
